Origin Sciences Puts Weinberger At The Helm
This article was originally published in Clinica
Executive Summary
Origin Sciences, an emerging UK firm focused on gastrointestinal disease detection and monitoring, has appointed Paul Weinberger as CEO and director. Weinberger is the first to fill this position; prior to the appointment, the responsibilities of chief executive had been split between Origin’s senior management team. The new CEO’s track record includes “high level roles” at various diagnostic firms such as Lumora, Enigma Diagnostics and Roche Diagnostics. He is also founder and CEO of Diasolve, which helps inventors and companies bring innovative diagnostic solutions to market. Origin last year launched OriCol, a sampling device for investigating gastrointestinal disease, and has been expanding its international commercial presence.